Literature DB >> 8665373

White-coat hypertension and cardiovascular risk.

G Cerasola1, S Cottone, E Nardi, G D'Ignoto, V Volpe, G Mulé, C Carollo.   

Abstract

OBJECTIVE: To compare cardiovascular risk in white-coat hypertensives, normotensives and established hypertensives.
METHODS: We studied 61 hypertensive individuals, 27 of whom were white-coat hypertensives, and 35 normotensives. All subjects underwent 24 h noninvasive blood pressure monitoring and Doppler echocardiographic examination of the heart; urine was tested for microalbuminuria and the fundi of the eyes examined for retinopathy.
RESULTS: The 24 h as well as the day- and night-time mean systolic blood pressure (SBP) was slightly but significantly higher in white-coat hypertensives than in normotensives; no significant difference was observed in diastolic blood pressure (DBP) between these groups. In white-coat hypertensives, 24 h SBP and DBP were lower than in established hypertensives (P < 0.001). The echocardiographic study showed higher values of posterior wall thickness, left ventricular mass index (LVMI), and ventricular septum thickness (P < 0.05) in white-coat hypertensives than in normotensives; fractional shortening and ejection fraction were similar. The E:A ratio, obtained from the Doppler study, was lower in white-coat hypertensives than in normotensives (1.14 +/- 0.3 versus 1.24 +/- 0.25; P < 0.05). LVMI values were smaller in white-coat hypertensives than in established hypertensives (P < 0.05), and both ejection fraction and fractional shortening were similar in the two groups. Among white-coat hypertensives, eight out of 27 showed hypertensive retinal damage; microalbuminuria values were similar to those obtained in normotensives.
CONCLUSIONS: The results of this cross-sectional and therefore limited study lead us to hypothesize that white-coat hypertensives are at higher risk than normotensives and lower risk than established hypertensives for developing cardiovascular damage.

Entities:  

Mesh:

Year:  1995        PMID: 8665373

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  6 in total

1.  Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension.

Authors:  Abdullah Shehab; Abdishakur Abdulle
Journal:  BMC Cardiovasc Disord       Date:  2011-01-11       Impact factor: 2.298

Review 2.  Treatment of white coat hypertension.

Authors:  S G Chrysant
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 3.  Blood pressure measurement: clinic, home, ambulatory, and beyond.

Authors:  Paul E Drawz; Mohamed Abdalla; Mahboob Rahman
Journal:  Am J Kidney Dis       Date:  2012-04-21       Impact factor: 8.860

4.  Prevalence and predictors of white-coat response in patients with treated hypertension.

Authors:  M B MacDonald; G P Laing; M P Wilson; T W Wilson
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

5.  Magnitude of the Difference Between Clinic and Ambulatory Blood Pressures and Risk of Adverse Outcomes in Patients With Chronic Kidney Disease.

Authors:  Elaine Ku; Raymond K Hsu; Delphine S Tuot; Se Ri Bae; Michael S Lipkowitz; Miroslaw J Smogorzewski; Barbara A Grimes; Matthew R Weir
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

6.  Does resting heart rate measured by the physician reflect the patient's true resting heart rate? White-coat heart rate.

Authors:  Benoit Lequeux; Charles Uzan; Michaela B Rehman
Journal:  Indian Heart J       Date:  2017-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.